Market Cap 5.36M
Revenue (ttm) 450,000.00
Net Income (ttm) -1.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -228.89%
Debt to Equity Ratio -1.80
Volume 4,100
Avg Vol 9,947
Day's Range N/A - N/A
Shares Out 2.20M
Stochastic %K 30%
Beta 1.27
Analysts Strong Buy
Price Target $6.00

Company Profile

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The com...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 611 6600
Address:
26 Ben-Gurion St., Ramat Gan, Israel
topstockalerts
topstockalerts Apr. 17 at 1:22 AM
After Hours Top Gainers PT2 $GXAI $SNAL $WSHP $OPRT $XTLB
0 · Reply
TwongStocks
TwongStocks Mar. 25 at 8:14 PM
Today's reverse split results. $ONCO 1 for 5 Previous close $0.5735, $2.8675 split-adjusted Intraday high $3.61 Today's close $3.03 🟢Up 5.67% $XTLB 1 for 4 Previous close $0.6530, $2.612 split-adjusted Intraday high $2.96 Today's close $2.71 🟢Up 3.75%
0 · Reply
UnicornPicks
UnicornPicks Mar. 25 at 2:04 PM
1 · Reply
TwongStocks
TwongStocks Mar. 25 at 12:51 PM
$ONCO $XTLB Both with reverse splits today. Trading is scheduled to resume at 9:00am ET, with the RS in effect. RS details in the quoted post.
0 · Reply
FreeBeerTomorrow
FreeBeerTomorrow Mar. 25 at 8:57 AM
$XTLB XTLB (XTL Biopharmaceuticals) has a reverse split-equivalent action taking effect today, March 25, 2026. ​Technically, the company is implementing an ADS Ratio Change, which functions exactly like a 1-for-4 reverse split for Nasdaq traders. ​Pre-Split Float: ~5.82M ​Post-Split Float: ~1.455M (Estimated)
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Mar. 25 at 4:04 AM
🌅 Watchlist part 3 ✅ $ITOC .45 support, if above .55, have potential to .75/.85 ✅ $BZAI 1.50 support, if above 1.75, have potential to 2/2.20 ✅ $XTLB 1/4 reverse split (RS), new price ~2.64 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $CSAI $IMUX still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
0 · Reply
TwongStocks
TwongStocks Mar. 24 at 8:06 PM
I am aware of two NASDAQ reverse splits scheduled on Wednesday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Wednesday morning. $ONCO 1 for 5. Will reduce outstanding shares from approx 3.58m to approx 717k. $XTLB 1 for 4. Will reduce outstanding ADS from approx 13.19m to approx 3.30m
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 24 at 4:22 AM
$XTLB RSI: 23.85, MACD: -0.0703 Vol: 0.08, MA20: 0.69, MA50: 0.82 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
TwongStocks
TwongStocks Mar. 23 at 6:30 PM
$XTLB Equity Corporate Actions Alert #2026 - 180 Information Regarding the Reverse Stock Split, Ratio Change and CUSIP Number Change for XTL Biopharmaceuticals Ltd. (XTLB) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-180 XTL Biopharmaceuticals Ltd. (XTLB) will effect a one-for-four (1-4) reverse split of its American Depositary Shares and ratio change from one (1) American Depositary Share representing one hundred (100) Ordinary Shares (1:100) to one (1) American Depositary Share representing four hundred (400) Ordinary Shares (1:400). The reverse stock split and ratio change will become effective on Wednesday, March 25, 2026. In conjunction with the reverse split, the CUSIP number will change to 98386D406.
0 · Reply
focafoca99
focafoca99 Feb. 28 at 7:21 AM
$XTLB Delist Determination notice received, at least they are going to request a hearing panel...
0 · Reply
Latest News on XTLB
XTL Biopharmaceuticals Announces ADS Ratio Change

Fri, 20 Mar 2026 16:10:00 -0400 - 5 weeks ago

XTL Biopharmaceuticals Announces ADS Ratio Change


XTL Biopharmaceuticals (XTLB) Faces Nasdaq Delisting Threat

2026-02-27T22:56:21.000Z - 2 months ago

XTL Biopharmaceuticals (XTLB) Faces Nasdaq Delisting Threat


XTL Update on Recent Developments

Thu, 29 Jan 2026 16:05:00 -0500 - 3 months ago

XTL Update on Recent Developments


XTL Names Mr. Noam Band as its New Chief Executive Officer

Mon, 07 Apr 2025 09:15:00 -0400 - 1 year ago

XTL Names Mr. Noam Band as its New Chief Executive Officer


XTL Entered Definitive Agreement to Acquire The Social Proxy

Wed, 05 Jun 2024 09:15:00 -0400 - 2 years ago

XTL Entered Definitive Agreement to Acquire The Social Proxy


XTL To Aquire The Social Proxy

Wed, 20 Mar 2024 10:15:00 -0400 - 2 years ago

XTL To Aquire The Social Proxy


topstockalerts
topstockalerts Apr. 17 at 1:22 AM
After Hours Top Gainers PT2 $GXAI $SNAL $WSHP $OPRT $XTLB
0 · Reply
TwongStocks
TwongStocks Mar. 25 at 8:14 PM
Today's reverse split results. $ONCO 1 for 5 Previous close $0.5735, $2.8675 split-adjusted Intraday high $3.61 Today's close $3.03 🟢Up 5.67% $XTLB 1 for 4 Previous close $0.6530, $2.612 split-adjusted Intraday high $2.96 Today's close $2.71 🟢Up 3.75%
0 · Reply
UnicornPicks
UnicornPicks Mar. 25 at 2:04 PM
1 · Reply
TwongStocks
TwongStocks Mar. 25 at 12:51 PM
$ONCO $XTLB Both with reverse splits today. Trading is scheduled to resume at 9:00am ET, with the RS in effect. RS details in the quoted post.
0 · Reply
FreeBeerTomorrow
FreeBeerTomorrow Mar. 25 at 8:57 AM
$XTLB XTLB (XTL Biopharmaceuticals) has a reverse split-equivalent action taking effect today, March 25, 2026. ​Technically, the company is implementing an ADS Ratio Change, which functions exactly like a 1-for-4 reverse split for Nasdaq traders. ​Pre-Split Float: ~5.82M ​Post-Split Float: ~1.455M (Estimated)
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Mar. 25 at 4:04 AM
🌅 Watchlist part 3 ✅ $ITOC .45 support, if above .55, have potential to .75/.85 ✅ $BZAI 1.50 support, if above 1.75, have potential to 2/2.20 ✅ $XTLB 1/4 reverse split (RS), new price ~2.64 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $CSAI $IMUX still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
0 · Reply
TwongStocks
TwongStocks Mar. 24 at 8:06 PM
I am aware of two NASDAQ reverse splits scheduled on Wednesday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Wednesday morning. $ONCO 1 for 5. Will reduce outstanding shares from approx 3.58m to approx 717k. $XTLB 1 for 4. Will reduce outstanding ADS from approx 13.19m to approx 3.30m
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 24 at 4:22 AM
$XTLB RSI: 23.85, MACD: -0.0703 Vol: 0.08, MA20: 0.69, MA50: 0.82 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
TwongStocks
TwongStocks Mar. 23 at 6:30 PM
$XTLB Equity Corporate Actions Alert #2026 - 180 Information Regarding the Reverse Stock Split, Ratio Change and CUSIP Number Change for XTL Biopharmaceuticals Ltd. (XTLB) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-180 XTL Biopharmaceuticals Ltd. (XTLB) will effect a one-for-four (1-4) reverse split of its American Depositary Shares and ratio change from one (1) American Depositary Share representing one hundred (100) Ordinary Shares (1:100) to one (1) American Depositary Share representing four hundred (400) Ordinary Shares (1:400). The reverse stock split and ratio change will become effective on Wednesday, March 25, 2026. In conjunction with the reverse split, the CUSIP number will change to 98386D406.
0 · Reply
focafoca99
focafoca99 Feb. 28 at 7:21 AM
$XTLB Delist Determination notice received, at least they are going to request a hearing panel...
0 · Reply
45IQ
45IQ Feb. 25 at 4:40 AM
$XAIR $XTLB XTL Approves cap raise and all proposals pertaining to purchasing 85% of neurons. https://www.google.com/amp/s/m.investing.com/news/sec-filings/xtl-biopharmaceuticals-shareholders-approve-share-capital-increase-and-private-placement-93CH-4522757%3fampMode=1
0 · Reply
LindaRice1041
LindaRice1041 Feb. 21 at 9:06 AM
$XTLB Xtrackers Long/Short Carbon ETF uses emissions strategy. Performance depends on carbon pricing. Volatility is elevated.
0 · Reply
anonAlb
anonAlb Feb. 18 at 3:41 PM
$SUGP we blowing up here soon! Load load load 🚨🚨🚨🚀🚀🚀🚀🚀 $XTLB $SENS
0 · Reply
CarlPhilipTrading
CarlPhilipTrading Feb. 18 at 3:37 PM
$SUGP if u missed $SNSE $XTLB SUGP be early Potential next 500k floater to go
0 · Reply
CandleVoyager
CandleVoyager Feb. 18 at 10:00 AM
$XTLB Energy infrastructure exposure where contract stability underpins valuation.
0 · Reply
Maggie_Pie
Maggie_Pie Feb. 17 at 11:52 PM
$XTLB I'm in for these cheapies. GL very
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 17 at 5:18 PM
$XTLB RSI: 47.69, MACD: 0.0089 Vol: 0.09, MA20: 0.93, MA50: 0.85 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Kesiya
Kesiya Feb. 17 at 1:59 PM
$XTLB Buying zone.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 1:13 PM
$XTLB RSI: 67.02, MACD: 0.0574 Vol: 0.18, MA20: 0.81, MA50: 0.83 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Frab
Frab Jan. 22 at 5:39 PM
0 · Reply
Hadaddy1211
Hadaddy1211 Jan. 21 at 5:26 PM
$XTLB why’s nobody talking about this!? Went up almost 60% in a week
1 · Reply